Amn Healthcare Services Inc (AMN) Stock Price & Analysis
Amn Healthcare Services Inc (AMN) fell 2.29% to USD 30.33 as of June 10, 2026 at 07:50 UTC, according to Nexqual real-time market data.
AMN last closed at USD 31.04; the session ranged USD 30.12–32.42 on volume of 770,544 shares. Market capitalization is $1.18B, with a 52-week range of USD 14.87–32.52 (NYQ). Source: Nexqual, June 10, 2026 at 07:50 UTC.
Key Statistics (as of June 10, 2026 at 07:50 UTC)
| Price | USD 30.33 |
|---|---|
| Change | ▼ 2.29% (down) |
| Previous Close | USD 31.04 |
| Open | USD 31.06 |
| Day Range | USD 30.12 – 32.42 |
| 52-Week Range | USD 14.87 – 32.52 |
| Volume | 770,544 shares |
| Market Cap | $1.18B |
| Exchange | NYQ |
Technical Analysis (AMN)
Nexqual's technical model rates AMN "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 07:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.65 (neutral) |
| vs SMA50 | Above (USD 23.69) |
| MACD | 1.98 (positive) |
Analyst Ratings (AMN)
Wall Street analysts rate AMN "Hold" based on 7 analysts, with a mean price target of USD 28.14 (range USD 22–36), per Nexqual as of June 10, 2026 at 07:50 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 28.14 |
| High Target | USD 36 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 3 / 5 / 1 |
Earnings (AMN)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.19 |
| Revenue Estimate | $627.11M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2.1 vs est 1.62 ▲ beat |
| 2025-12-31 | USD 0.22 vs est 0.27 ▼ miss |
| 2025-09-30 | USD 0.39 vs est 0.2 ▲ beat |
| 2025-06-30 | USD 0.3 vs est 0.19 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:50 UTC.
Financials & Fundamentals (AMN)
| Total Revenue | $3.42B |
|---|---|
| Revenue Growth (YoY) | +99.90% |
| Gross Margin | +27.63% |
| Operating Margin | +8.50% |
| Profit Margin | -0.95% |
| ROE | -4.54% |
| Debt / Equity | 108.99 |
| Current Ratio | 1.09 |
| Total Cash | $560.74M |
| Total Debt | $776.92M |
| Free Cash Flow | $671.52M |
Source: Nexqual, June 10, 2026 at 07:50 UTC.
Financial Health Score (AMN)
Nexqual rates Amn Healthcare Services Inc's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:50 UTC.
| Growth | Weak — Revenue -8% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 28%, operating 9% |
| Balance Sheet | Mixed — $561M cash vs $777M debt |
| Cash Flow | Strong — FCF $672M, 25% margin |
| Efficiency | Critical — ROE -5%, ROA 3.4% |
Ownership (AMN)
| Insider Ownership | +0.99% |
|---|---|
| Institutional Ownership | +115.67% |
| Shares Outstanding | 38.79M |
| Float | 38.39M |
| Short % of Float | +8.39% |
Source: Nexqual, June 10, 2026 at 07:50 UTC.
Leadership (AMN)
Amn Healthcare Services Inc is led by Caroline Sullivan Grace (age 56), President, CEO & Director, per Nexqual as of June 10, 2026 at 07:50 UTC.
| President, CEO & Director | Caroline Sullivan Grace (age 56) |
|---|---|
| CFO & COO | Brian M. Scott (age 55) |
| Division President of Technology and Workforce Solutions | Nishan Sivathasan |
| Senior Director of Investor Relations & Strategy | Randle G. Reece |
| Chief Marketing Officer | Kerry Perez |
Major Backers & Investors (AMN)
Notable institutional backers of Amn Healthcare Services Inc include Boston Partners, Two Sigma Investments, LP, Arrowstreet Capital, Limited Partnership, according to Nexqual as of June 10, 2026 at 07:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Boston Partners | 5.51% |
| Two Sigma Investments, LP | 4.09% |
| Arrowstreet Capital, Limited Partnership | 3.61% |
| Renaissance Technologies | 3.55% |
| Morgan Stanley | 3.46% |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 2.1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 24.82% |
| Vanguard Group | 11.44% |
| State Street | 5.07% |
| Allianz Asset Management GmbH | 3.25% |
Source: Nexqual, June 10, 2026 at 07:50 UTC.
From Amn Healthcare Services Inc's Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- —Our Services." We believe we are recognized as a market-leading innovator in providing healthcare talent solutions in the United States.
- SG&A expenses were $593.0 million, representing 21.7% of revenue, for 2025, as compared to $632.5 million, representing 21.2% of revenue, for 2024.
- In our technology and workforce solutions segment, our language services business experienced a seasonal drop in minutes sequentially in the fourth quarter, but minutes for the full year were higher than prior year.
- For 2025 and 2024, revenue under our MSP arrangements comprised approximately 48% and 45% of our consolidated revenue, 71% and 67% for nurse and allied solutions segment revenue, 18% and 15% for physician and leadership solutions segment revenue, and 3% and 3% of our technology and workforce solutions segment revenue, respectively.
Partnerships
- During 2025, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments and our investment portfolio.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCRN | Cross Country Healthcare, Inc. | USD 13.18 | ▲ 0% |
| ATKR | Atkore Inc. | USD 80.78 | ▲ 0.21% |
| AIN | Albany International Corporatio | USD 69.52 | ▲ 2.63% |
| EHC | Encompass Health Corporation | USD 104.19 | ▲ 0.17% |
| BOOT | Boot Barn Holdings, Inc. | USD 170.81 | ▲ 1.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:50 UTC. This page is informational and not investment advice.